[Childhood leukemia: a genetic disease!].
Cancer affects 1 in every 500 children before the age of 14. Little is known about the etiology of this heterogeneous group of diseases despite the fact that they constitute the major cause of death by disease among this population. Because of its relatively higher prevalence, most of the work done in pediatric oncogenetics has been focused on leukemias, particularly acute lymphoblastic leukemia (ALL). Although it is now well accepted that genetic variations play a significant role in determining individual's cancer susceptibility, few studies have explored genetic susceptibility to childhood leukemia with respect to polymorphisms. The main biological mechanisms contributing to cancer susceptibility can be grouped into broad categories : (1) cellular growth and differentiation, (2) DNA replication and repair, (3) xenobiotic metabolism, (4) apoptosis, (5) oxidative stress response and (6) cell cycle. To evaluate whether candidate genes in these pathways are involved in childhood leukemogenesis, we conducted association studies. We showed that leukemogenesis in children may be associated with genetic variants and that the combination of genotypes seems to be more predictive of risk than either of them independently. These results indicate that the genetic investigation of several enzymes (or metabolic pathways) is needed to explain the physiopathology of childhood leukemia because of the complexity of the environment and that of the inter-individual variability in cancer susceptibility.
Sinnett
Daniel
D
Service d'Hématologie-Oncologie, Centre de Cancérologie Charles-Bruneau, Centre de Recherche, Hôpital Sainte-Justine, Québec, Canada. daniel.sinnett@umontreal.ca
N'Diaye
Nina
N
St-Onge
Pascal
P
Healy
Jasmine
J
D002648:Child; D004781:Environmental Exposure; D006801:Humans; D007938:Leukemia / Q000453:epidemiology* / Q000209:etiology / Q000235:genetics*; D016877:Oxidants / Q000633:toxicity; D015262:Xenobiotics / Q000493:pharmacokinetics / Q000633:toxicity
D016877:Oxidants; D015262:Xenobiotics